Results 241 to 250 of about 192,948 (305)

Increased ATP production and P‐glycoprotein activity underlie the marked changes in blood–brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and purpose Patients with amyotrophic lateral sclerosis (ALS) are prescribed many medications for symptomatic relief. However, how potential alterations to the blood–brain barrier (BBB) affect the brain exposure of drugs in ALS remains under‐investigated. Experimental approach We used high‐dimensional proteomic analysis, cellular metabolism,
Yijun Pan   +10 more
wiley   +1 more source

Non‐canonical PKG1 regulation in cardiovascular health and disease

open access: yesBritish Journal of Pharmacology, EarlyView.
It is well established that the cyclic GMP‐dependent protein kinase I (PKG1) is canonically activated by cyclic guanosine monophosphate (cGMP), enabling its regulation of vascular tone, cardiac function and smooth muscle homeostasis. However, diverse non‐canonical stimuli of PKG1 have also been identified.
Jie Su, Joseph Robert Burgoyne
wiley   +1 more source

Right ventricular dysfunctions in type 1 diabetic mice: A longitudinal study. [PDF]

open access: yesWorld J Diabetes
Yu JJ   +7 more
europepmc   +1 more source

Hypertrophic Cardiomyopathy in a Fetus: A Rare Presentation Case Report. [PDF]

open access: yesClin Case Rep
Golbabaei A   +3 more
europepmc   +1 more source

Blood Pressure Variability in Hypertension: A Rehabilitation Perspective. [PDF]

open access: yesJ Cardiovasc Dev Dis
Raju M   +3 more
europepmc   +1 more source

Atrioventricular Block in a Pompe Disease Patient Receiving Enzyme Replacement Therapy. [PDF]

open access: yesJACC Case Rep
Akagi K   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy